Nizatidine Capsules Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 150 mg
Reference Brands: Axid(US & EU)
Category:
Gastrointestinal Drugs
Nizatidine capsules are H2-receptor antagonists that block histamine effects on gastric acid secretion in the stomach lining. They reduce gastric acid production, alleviating acid reflux, ulcers, and GERD symptoms. Benefits include symptom relief, mucosal healing, and prevention of ulcer complications, supporting gastrointestinal health effectively.
Nizatidine capsules is available in Capsules
and strengths such as 150 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Nizatidine capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Nizatidine capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Nizatidine capsules, marketed as Axid, are approved in the US by the FDA and in the EU via EMA for treating gastric ulcers, GERD, and Zollinger-Ellison syndrome. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For detailed guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe use, and global availability of nizatidine capsules, helping improve gastrointestinal health and prevent ulcer complications worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing